HK1201517A1 - Process for preparing quinoline derivatives - Google Patents

Process for preparing quinoline derivatives

Info

Publication number
HK1201517A1
HK1201517A1 HK15101949.3A HK15101949A HK1201517A1 HK 1201517 A1 HK1201517 A1 HK 1201517A1 HK 15101949 A HK15101949 A HK 15101949A HK 1201517 A1 HK1201517 A1 HK 1201517A1
Authority
HK
Hong Kong
Prior art keywords
quinoline derivatives
preparing quinoline
preparing
derivatives
quinoline
Prior art date
Application number
HK15101949.3A
Other languages
English (en)
Chinese (zh)
Inventor
Jo Ann Wilson
Sriram Naganathan
Matthew Pfeiffer
Neil G Andersen
Original Assignee
Exelixis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exelixis Inc filed Critical Exelixis Inc
Publication of HK1201517A1 publication Critical patent/HK1201517A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/58—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/59—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
HK15101949.3A 2011-10-20 2015-02-26 Process for preparing quinoline derivatives HK1201517A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161549312P 2011-10-20 2011-10-20
PCT/US2012/061320 WO2013059788A1 (en) 2011-10-20 2012-10-22 Process for preparing quinoline derivatives

Publications (1)

Publication Number Publication Date
HK1201517A1 true HK1201517A1 (en) 2015-09-04

Family

ID=47146705

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15101949.3A HK1201517A1 (en) 2011-10-20 2015-02-26 Process for preparing quinoline derivatives

Country Status (24)

Country Link
US (3) US9365516B2 (es)
EP (1) EP2768796B1 (es)
JP (2) JP6208140B2 (es)
KR (1) KR102075371B1 (es)
CN (2) CN104395284A (es)
AR (1) AR088483A1 (es)
AU (2) AU2012325768B2 (es)
BR (1) BR112014009302B1 (es)
CA (1) CA2852771C (es)
DK (1) DK2768796T3 (es)
EA (1) EA031485B1 (es)
ES (1) ES2765013T3 (es)
GE (1) GEP20207110B (es)
HK (1) HK1201517A1 (es)
HU (1) HUE048023T2 (es)
IL (1) IL232139A (es)
IN (1) IN2014CN02971A (es)
MX (1) MX343288B (es)
PL (1) PL2768796T3 (es)
PT (1) PT2768796T (es)
TW (2) TWI642650B (es)
UA (1) UA116876C2 (es)
WO (1) WO2013059788A1 (es)
ZA (1) ZA201402579B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ607118A (en) 2010-07-16 2015-05-29 Exelixis Inc C-met modulator pharmaceutical compositions
EP2621481B2 (en) 2010-09-27 2022-10-19 Exelixis, Inc. Dual inhibitors of met and vegf for the treatment of castration-resistant prostate cancer and osteoblastic bone metastases
EP4019498A1 (en) 2011-02-10 2022-06-29 Exelixis, Inc. Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
US20120252840A1 (en) 2011-04-04 2012-10-04 Exelixis, Inc. Method of Treating Cancer
KR20140025496A (ko) 2011-05-02 2014-03-04 엑셀리시스, 인코포레이티드 암 및 뼈 암 통증의 치료방법
CN103957915A (zh) 2011-09-22 2014-07-30 埃克塞里艾克西斯公司 治疗骨质疏松症的方法
ES2765013T3 (es) * 2011-10-20 2020-06-05 Exelixis Inc Procedimiento para preparar derivados de quinolina
JP2015515988A (ja) 2012-05-02 2015-06-04 エクセリクシス， インク． 溶骨性骨転移を治療するためのｍｅｔ−ｖｅｇｆ二重調節剤
WO2014145715A1 (en) 2013-03-15 2014-09-18 Exelixis, Inc. Metabolites of n-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide
WO2014165786A1 (en) 2013-04-04 2014-10-09 Exelixis, Inc. Cabozantinib dosage form and use in the treatment of cancer
CN104649969B (zh) * 2013-11-22 2019-02-12 广东东阳光药业有限公司 一种替尼类药物的盐及其制备方法
CA3181899A1 (en) 2014-02-14 2015-08-20 Exelixis, Inc. Crystalline solid forms of n-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
EA201691850A1 (ru) 2014-03-17 2016-12-30 Экселиксис, Инк. Дозирование составов, содержащих кабозантиниб
CN104788372B (zh) * 2014-07-25 2018-01-30 上海圣考医药科技有限公司 一种氘代卡博替尼衍生物、其制备方法、应用及其中间体
CA2956810C (en) 2014-07-31 2022-10-04 Exelixis, Inc. Method of preparing fluorine-18 labeled cabozantinib and its analogs
BR112017002318A2 (pt) 2014-08-05 2018-07-17 Exelixis, Inc. combinações de fármacos para tratar mieloma múltiplo.
CN108026035B (zh) * 2015-09-02 2021-03-30 陈昆锋 具有蛋白酪氨酸磷酸酶shp-1激动剂活性的化合物
CA3020749A1 (en) 2016-04-15 2017-10-19 Exelixis, Inc. Method of treating renal cell carcinoma using n-(4-(6,7-dimethoxyquinolin-4-yloxy) phenyl)-n'-(4-fluoropheny)cyclopropane-1,1-dicarboxamide, (2s)-hydroxybutanedioate
CN109836382B (zh) * 2017-11-29 2021-11-05 江苏豪森药业集团有限公司 苹果酸卡博替尼及其中间体的制备方法
JP7321165B2 (ja) 2018-01-26 2023-08-04 エグゼリクシス， インコーポレイテッド キナーゼ依存的障害を処置するための化合物
CN112142619B (zh) * 2020-10-20 2023-01-10 浙江工业大学 一种1,1-环丙烷二羧酸酰胺类化合物及其制备方法和应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2210607T3 (da) 2003-09-26 2011-12-12 Exelixis Inc N-[3-fluor-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorphenyl)cyclopropan-1,1-dicarboxamid til behandling af kræft
US7977345B2 (en) 2004-07-02 2011-07-12 Exelixis, Inc. c-MET modulators and method of use
CA2603748A1 (en) 2005-04-06 2006-10-12 Exelixis, Inc. C-met modulators and methods of use
CN101605540A (zh) 2006-12-14 2009-12-16 埃克塞利希斯股份有限公司 使用mek抑制剂的方法
UY31800A (es) 2008-05-05 2009-11-10 Smithkline Beckman Corp Metodo de tratamiento de cancer usando un inhibidor de cmet y axl y un inhibidor de erbb
WO2009136663A1 (en) * 2008-05-08 2009-11-12 Takeda Pharmaceutical Company Limited Fused heterocyclic derivatives and use thereof
TW201035017A (en) * 2008-09-26 2010-10-01 Smithkline Beecham Corp Preparation of a quinolinyloxydiphenylcyclopropanedicarboxamide
CA2743416A1 (en) 2008-11-13 2010-05-20 Exelixis Inc. Methods of preparing quinoline derivatives
US20130030172A1 (en) 2008-12-04 2013-01-31 Exelixis, Inc. Methods of Preparing Quinoline Derivatives
WO2010083414A1 (en) 2009-01-16 2010-07-22 Exelixis, Inc. Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quin0lin-4-yl] oxy}phenyl-n' - (4 -fluorophenyl) cyclopropane-1-dicarboxamide, and crystalline forms therof for the treatment of cancer
AU2010274012A1 (en) 2009-07-17 2012-02-09 Exelixis, Inc. Crystalline forms of N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy] -quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1, 1-dicarboxamide
UA108618C2 (uk) 2009-08-07 2015-05-25 Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку
JP2013522232A (ja) 2010-03-12 2013-06-13 エグゼリクシス， インコーポレイテッド Ｎ−［３−フルオロ−４−（｛６−（メチロキシ）−７−［（３−モルホリン−４−イルプロピル）オキシ］−キノリン−４−イル｝オキシ）フェニル］−ｎ’−（４−フルオロフェニル）シクロプロパン−１，１−ジカルボサミドの水和結晶性形状
US20120070368A1 (en) 2010-04-16 2012-03-22 Exelixis, Inc. Methods of Using C-Met Modulators
NZ607118A (en) 2010-07-16 2015-05-29 Exelixis Inc C-met modulator pharmaceutical compositions
WO2012009723A1 (en) 2010-07-16 2012-01-19 Exelixis, Inc. C-met modulator pharmaceutical compositions
CA2812753A1 (en) 2010-09-27 2012-04-05 Exelixis, Inc. Dual inhibitors of met and vegf for the treatment of castration resistant prostate cancer and osteoblastic bone metastases
WO2012044577A1 (en) 2010-09-27 2012-04-05 Exelixis, Inc. Dual inhibitors of met and vegf for the treatment of castration resistant prostate cancer and osteoblastic bone metastases
EP2621481B2 (en) 2010-09-27 2022-10-19 Exelixis, Inc. Dual inhibitors of met and vegf for the treatment of castration-resistant prostate cancer and osteoblastic bone metastases
CN103327979A (zh) 2010-11-22 2013-09-25 葛兰素史密斯克莱知识产权（第2号）有限公司 治疗癌症的方法
EP4019498A1 (en) 2011-02-10 2022-06-29 Exelixis, Inc. Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
US20120252840A1 (en) 2011-04-04 2012-10-04 Exelixis, Inc. Method of Treating Cancer
KR20140025496A (ko) 2011-05-02 2014-03-04 엑셀리시스, 인코포레이티드 암 및 뼈 암 통증의 치료방법
TW201306842A (zh) 2011-06-15 2013-02-16 Exelixis Inc 使用ｐｉ３ｋ／ｍｔｏｒ吡啶並嘧啶酮抑制劑及苯達莫司汀及／或利妥昔單抗治療惡性血液疾病之組合療法
CN103957915A (zh) 2011-09-22 2014-07-30 埃克塞里艾克西斯公司 治疗骨质疏松症的方法
ES2765013T3 (es) * 2011-10-20 2020-06-05 Exelixis Inc Procedimiento para preparar derivados de quinolina
MX2014005458A (es) 2011-11-08 2015-04-16 Exelixis Inc Inhibidor doble de met y del factor de crecimiento endotelial vascular (vegf) para el tratamiento del cáncer.
JP2015515988A (ja) 2012-05-02 2015-06-04 エクセリクシス， インク． 溶骨性骨転移を治療するためのｍｅｔ−ｖｅｇｆ二重調節剤
US20150238477A1 (en) 2012-09-07 2015-08-27 Exelixis, Inc. Method of Treating Lung Adenocarcinoma

Also Published As

Publication number Publication date
MX2014004583A (es) 2014-10-06
US9365516B2 (en) 2016-06-14
TWI619694B (zh) 2018-04-01
US20160229805A1 (en) 2016-08-11
JP6208140B2 (ja) 2017-10-04
BR112014009302B1 (pt) 2020-04-28
TWI642650B (zh) 2018-12-01
EP2768796A1 (en) 2014-08-27
KR20140088874A (ko) 2014-07-11
ZA201402579B (en) 2015-03-25
AR088483A1 (es) 2014-06-11
EP2768796B1 (en) 2019-11-20
PT2768796T (pt) 2020-02-21
IN2014CN02971A (es) 2015-07-03
NZ624328A (en) 2016-10-28
CA2852771C (en) 2019-11-26
CN110511158A (zh) 2019-11-29
JP2014530880A (ja) 2014-11-20
US9969692B2 (en) 2018-05-15
AU2012325768B2 (en) 2017-08-10
NZ723880A (en) 2018-03-23
UA116876C2 (uk) 2018-05-25
AU2012325768A1 (en) 2014-05-22
IL232139A0 (en) 2014-05-28
MX343288B (es) 2016-11-01
DK2768796T3 (da) 2020-02-24
GEAP201913471A (en) 2019-10-25
EA201490831A1 (ru) 2014-09-30
AU2017254982A1 (en) 2017-11-23
CN104395284A (zh) 2015-03-04
TW201321342A (zh) 2013-06-01
TW201731812A (zh) 2017-09-16
PL2768796T3 (pl) 2020-05-18
GEP20207110B (en) 2020-05-25
KR102075371B1 (ko) 2020-02-10
JP2017222648A (ja) 2017-12-21
BR112014009302A2 (pt) 2017-05-23
CA2852771A1 (en) 2013-04-25
IL232139A (en) 2017-11-30
US20140256938A1 (en) 2014-09-11
US20180230100A1 (en) 2018-08-16
WO2013059788A1 (en) 2013-04-25
ES2765013T3 (es) 2020-06-05
EA031485B1 (ru) 2019-01-31
HUE048023T2 (hu) 2020-05-28

Similar Documents

Publication Publication Date Title
HK1201517A1 (en) Process for preparing quinoline derivatives
HK1214239A1 (zh) 製備膽汁酸衍生物的方法
IL222290A0 (en) Process for preparing aminobenzofuran derivatives
IL222191A0 (en) Process for preparing sulfonamido-benzofuran derivatives
IL230594A (en) The process of making compounds 1h- pyridine-5-carbonyl chloride is converted into nitrogen
ZA201305582B (en) Process for the preparation of 4-amino-5-fluoro-3-halo-6-(sunstituted)picolinates
IL227872A0 (en) A process for the preparation of n-converted phenylhydroxylamines
ZA201304330B (en) Method for preparing 2-aminobenzamide derivatives
ZA201402624B (en) Process for preparing buprenorphine
ZA201207386B (en) Process for preparing benzoxaboroles
EP2707367A4 (en) PROCESS FOR THE PRODUCTION OF NAPHTHYRIDINES
IL227220A (en) A process for preparing a history of 3-alkylsulfinylbenzoyl
HK1214599A1 (zh) 製備 -甲酰基-頭孢霉毒核衍生物的氧化方法
SG11201401572SA (en) Processes for preparing indoles
EP2619174A4 (en) PROCESS FOR THE PREPARATION OF L-PHENYL-3-DIMETHYLAMINOPROPANE DERIVATIVES
EP2855433A4 (en) PROCESS FOR THE PREPARATION OF DIHALOPYRIDINES
EP2819995A4 (en) PROCESS FOR THE PREPARATION OF 3-METHYLSULFONYLPROPIONITRIL
IL223145A0 (en) Process for preparing dithiine-tetracarboxy-diimides
EP2585436A4 (en) PROCESS FOR THE PREPARATION OF 4-HYDROXYPYRIDINES
PL2940000T3 (pl) Sposób wytwarzania octanu metylu
EP2662376A4 (en) PROCESS FOR THE PRODUCTION OF TORISEL
IL235300A0 (en) A process for the preparation of naphthyridine hist
IL238934A (en) Methods for making phenyloxymethyl-nitro-imidazole derivatives